|
|
||||||||
Case Report |
JOHN P. KNOR, PHARM.D., is Postgraduate Year One Pharmacy Resident, Albert Einstein Medical Center, Philadelphia, PA. MERSEDEH MOSHFEGHI, PHARM.D., is Clinical Coordinator, Pharmacy Department; and MARY C. SOKOLOSKI, M.D., is Pediatric Cardiologist, Cardiology Department, St. Christophers Hospital for Children, Philadelphia.
Address correspondence to Dr. Knorr at the Albert Einstein Medical Center, Department of Pharmacy, 5501 Old York Road, Philadelphia, PA 19141 (knorr.john{at}gmail.com).
Summary. A 16-year-old boy arrived at a childrens hospital reporting mucous diarrhea that had lasted two weeks, light-headedness with two blackouts on the day before his arrival to the hospital, and a 4.3-kg weight loss over the previous three weeks. He had a 3.5-year history of Crohns disease and had been hospitalized for two months with a diagnosis of colitis with cryptitis. He was admitted for the treatment of an acute flare of Crohns disease and a perirectal abscess. The patient was started on i.v. ciprofloxacin 400 mg twice daily and metronidazole 500 mg every six hours. The selected agents provided adequate empirical coverage of the suspected organisms and would not be contraindicated with the patients allergy to penicillin. Within 48 hours of administration of ciprofloxacin, the patient became bradycardic. The cardiology service was consulted, and an electrocardiogram showed a mildly prolonged Q-T interval (corrected Q-T interval, 486 msec) and low heart rate (42 beats/min). Antimicrobial therapy was changed to ampicillin and then to linezolid. The patients Q-T interval normalized within seven days of ciprofloxacin discontinuation. The patient had no further cardiac anomalies. Two weeks later, he was discharged on linezolid and aztreonam for the treatment of his abscess and was responding to treatment.
Conclusion. A pediatric patient with Crohns disease and colitis with cryptitis developed a prolonged Q-T interval within 48 hours of treatment with ciprofloxacin.
Index terms: Ciprofloxacin; Crohn disease; Long QT syndrome; Metronidazole; Pediatrics; Quinolones; Toxicity
Purpose. A case of Q-T interval prolongation in a pediatric patient with no known risk factors for the development of a long Q-T syndrome is reported.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |